1257 related articles for article (PubMed ID: 29188510)
21. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
22. CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.
Babačić H; Mehta A; Merkel O; Schoser B
PLoS One; 2019; 14(2):e0212198. PubMed ID: 30794581
[TBL] [Abstract][Full Text] [Related]
23. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
Bak RO; Porteus MH
Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
[TBL] [Abstract][Full Text] [Related]
24. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
[TBL] [Abstract][Full Text] [Related]
25. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
Sandoval IM; Collier TJ; Manfredsson FP
Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
[TBL] [Abstract][Full Text] [Related]
26. Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain.
Nishiyama J; Mikuni T; Yasuda R
Neuron; 2017 Nov; 96(4):755-768.e5. PubMed ID: 29056297
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas9 DNA Base-Editing and Prime-Editing.
Kantor A; McClements ME; MacLaren RE
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872311
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
30. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
31. [Application and optimization of CRISPR/Cas system in bacteria].
Fu J; Yang F; Xie H; Gu F
Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
[TBL] [Abstract][Full Text] [Related]
32. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
33. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
34. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
Alagoz Y; Gurkok T; Zhang B; Unver T
Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
[TBL] [Abstract][Full Text] [Related]
35. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
36. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
37. Visualization analysis of CRISPR/Cas9 gene editing technology studies.
Du QS; Cui J; Zhang CJ; He K
J Zhejiang Univ Sci B; 2016 Oct.; 17(10):798-806. PubMed ID: 27704749
[TBL] [Abstract][Full Text] [Related]
38. Genome editing in the mammalian brain using the CRISPR-Cas system.
Nishiyama J
Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
[TBL] [Abstract][Full Text] [Related]
39. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
40. Genome editing abrogates angiogenesis in vivo.
Huang X; Zhou G; Wu W; Duan Y; Ma G; Song J; Xiao R; Vandenberghe L; Zhang F; D'Amore PA; Lei H
Nat Commun; 2017 Jul; 8(1):112. PubMed ID: 28740073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
